financetom
Business
financetom
/
Business
/
Goldman Sachs, Carlyle, Jefferies Downgraded by Oppenheimer Amid 'Likely' Delayed or Cancelled M&A Rebound
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Goldman Sachs, Carlyle, Jefferies Downgraded by Oppenheimer Amid 'Likely' Delayed or Cancelled M&A Rebound
Mar 19, 2025 7:39 AM

10:25 AM EDT, 03/19/2025 (MT Newswires) -- Goldman Sachs Group ( GS ) , Carlyle Group ( CG ) and Jefferies Financial Group ( JEF ) were downgraded by Oppenheimer to perform from outperform amid the "likely" delayed or cancelled rebound in M&A activity this year.

"We fear that the current uncertainty over tariffs, a fiscal 'detox' and the general upheaval of 80 years of trade and security arrangements is likely to cause a pause in M&A activity," Oppenheimer said in a note Wednesday.

The firm said that coming into the year, it was "very optimistic about a major rebound" in M&A and its attendant financing due to pent-up demand, stable to lower interest rates, tight credit spreads and "generally strong" public market stock valuations.

But Oppenheimer said there has been "no visible sign of this M&A rebound" so far.

Price: 550.38, Change: -1.40, Percent Change: -0.25

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
IntelGenx Updates Status of Buprenorphine Buccal Film ANDA
IntelGenx Updates Status of Buprenorphine Buccal Film ANDA
Apr 5, 2024
08:10 AM EDT, 04/05/2024 (MT Newswires) -- IntelGenx Corp. (IGX.TO) on Friday said its co-developer, Chemo Research SL, through its agent and affiliate, Xiromed LLC, has received a Complete Response Letter (CRL) from the FDA regarding its resubmitted abbreviated new drug application (ANDA) for Buprenorphine Buccal Film. The CRL includes a request for additional Pharmaceutical Quality information. The FDA confirmed...
Dye & Durham Announces Pricing of Refinancing Transactions
Dye & Durham Announces Pricing of Refinancing Transactions
Apr 5, 2024
08:06 AM EDT, 04/05/2024 (MT Newswires) -- Dye & Durham Ltd. ( DYNDF ) , provider of cloud-based legal practice management software, on Friday priced and allocated US$350 million aggregate principal amount of its senior secured term Loan B facility. It will also enter into its C$105 million revolving credit facility and price US$555 million aggregate principal amount of its...
Sector Update: Consumer
Sector Update: Consumer
Apr 5, 2024
08:10 AM EDT, 04/05/2024 (MT Newswires) -- Consumer stocks were advancing pre-bell Friday, with the Consumer Staples Select Sector SPDR Fund (XLP) up 0.3% and the Consumer Discretionary Select Sector SPDR Fund (XLY) 0.5% higher. Highwoods Properties ( HIW ) stock was down 2.3% after the company said overnight it sold non-core properties in Raleigh for gross proceeds of $79.4...
CrowdStrike Holdings Insider Sold Shares Worth $4,752,358, According to a Recent SEC Filing
CrowdStrike Holdings Insider Sold Shares Worth $4,752,358, According to a Recent SEC Filing
Apr 5, 2024
08:12 AM EDT, 04/05/2024 (MT Newswires) -- Gandhi Sameer K, Director, on April 03, 2024, sold 15,000 shares in CrowdStrike Holdings ( CRWD ) for $4,752,358. Following the Form 4 filing with the SEC, Gandhi Sameer K has control over a total of 1,112,378 shares of the company, with 6,106 shares held directly and 1,106,272 shares controlled indirectly. SEC Filing:...
Copyright 2023-2026 - www.financetom.com All Rights Reserved